Characterization of Suicidal Depression
1 other identifier
observational
898
1 country
1
Brief Summary
Antidepressants are widely used to prevent suicidal risk. However, even though the use of antidepressants has been associated with a 40-60% decrease in suicidal risk, they do not seem to be sufficient and appropriate. Indeed recent studies have shown that patients with a history of suicide attempt and/or with current suicidal ideation (SI) respond less well to antidepressant treatments. This suggests that patients with depression with SI may be different from those with depression without SI, thus requiring specific treatments for both SI reduction and depressive remission. In other words, suicidal depression may be a specific subtype of depression. The study aims to characterize the clinical phenotype of patients with suicidal depression vs. those without suicidal depression, and to assess the occurrence of suicidal events at one year in patients with suicidal depression vs. without suicidal depression. All data having already been collected during the particpation of patients in various clinical research studies of the department
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
July 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedFirst Posted
Study publicly available on registry
September 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedNovember 15, 2021
November 1, 2021
3 months
July 5, 2021
November 12, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
characterization of the patient clinical phenotype
characterization of the patient clinical phenotype
day 1
Secondary Outcomes (3)
Suicidal events at one year
1 year
Hospitalization for suicidal ideation
1 year
Suicidal events at one year
1 year
Eligibility Criteria
Depressed patients with and without suicidal ideation, admitted to the Department of Emergency Psychiatry and Acute Care (Montpellier University Hospital) and enrolled in one of the department's clinical studies.
You may qualify if:
- Over 18 years old
- Hospitalization in the Department of Emergency Psychiatry and Acute Care (Montpellier University Hospital) between 2012 and 2019
- Having being enrolled in one the department's clinical studies between 2012 and 2019
- Moderate to severe characterized depressive episode according to DSM-5 diagnostic criteria (severity assessed with BDI, IDSC-30 and QIDS)
You may not qualify if:
- Protection by law (guardianship or curatorship)
- Deprivation of liberty (by judicial or administrative decision)
- Bipolar disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uhmontpellier
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bénédicte NOBILE, PharmD, PhD
University Hospital, Montpellier
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 5, 2021
First Posted
September 16, 2021
Study Start
June 1, 2021
Primary Completion
September 1, 2021
Study Completion
September 30, 2021
Last Updated
November 15, 2021
Record last verified: 2021-11